P21 (CNTF-Derived Peptide) Side Effects: Safety Signals and Warnings
P21 (CNTF-Derived Peptide) safety concerns are compound-specific. The main listed side effects are No significant adverse effects reported in animal studies and Potential unknown risks in humans. The main warning signals are No human trials have been conducted, Long-term effects of chronic neurogenesis stimulation are unknown, and Theoretical risk of promoting uncontrolled cell proliferation.
Direct Answer
Evidence for P21 Peptide is too preliminary to support a research protocol with confidence. Published data is extremely limited - a handful of in vitro and rodent studies, with no human pharmacokinetic data or clinical trials. Of the Cognitive & Nootropic compounds in this library, cerebrolysin has vastly more clinical evidence as a starting point.
- Evidence grade
- Level D
- Research status
- Preclinical
- Category
- Cognitive & Nootropic
- Best for
- CNTF pathway mechanistic research (preclinical only)
Reported Side Effects
- No significant adverse effects reported in animal studies
- Potential unknown risks in humans
Warnings
- No human trials have been conducted
- Long-term effects of chronic neurogenesis stimulation are unknown
- Theoretical risk of promoting uncontrolled cell proliferation
Known or Plausible Interactions
- Neurotrophic factors (BDNF, NGF - potential synergy)
- CNTF-based therapies (overlapping pathways)
- Lithium (both affect GSK-3beta)
Regulatory Context
Research compound only; not available for human use.
Evidence Snapshot
| Evidence grade | Level D |
|---|---|
| Research status | Preclinical |
| Best supported outcomes | Hippocampal Neurogenesis (Level D), Tau Pathology Reduction (Level D), and Spatial Memory (Level D) |
| Primary citation count | 2 |
| Last reviewed | 2026-04-04 |
Related Guides
How to Cite This Page
ExaminePeptides. "P21 (CNTF-Derived Peptide) Side Effects: Safety Signals and Warnings." Last reviewed 2026-04-04. https://examinepeptides.com/answers/p21-peptide-side-effects-safety/
This static answer page is built for fast indexing and direct citation. It summarizes the matching full evidence review and links back to primary sources where the source database includes them.